AzTrials
AzTrials

LonelinessINACTNCT07154225

INcreasing Adolescent Social and Community SupporT - Full Trial

A study testing Social Prescribing and Signposting in people with Loneliness, run by University College, London at 1 site in United Kingdom.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Background: Social Prescribing is a mechanism of connecting patients with non-medical forms of support within the community and has been shown to improve loneliness. Yet update from young people has been lower than for adults. Read more about this study

Who is it for?
Ages 9 to 14 years
Conditions the study is for
Loneliness
What is being tested?
Social Prescribing and Signposting
Could I receive a placebo?
No, everyone receives an active treatment
How many people
215 participants
Where
1 siteUnited Kingdom
Study dates
15 Sep 2025to 30 Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 9 to 14 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Schools:
  • A primary or secondary school willing to participate in INACT
  • In England
  • Have classes of pupils in eligible year groups to participate (Years 5, 7, 8)
  • Pupils and their parents/guardians:
  • Score 7 or above on the Good Childhood Index (indicating high loneliness)
  • Parents/guardians consent, and pupils assent, to get support

Who cannot join

  • Schools:
  • Private schools or sixth form/colleges
  • Specialist schools
  • Schools only offering alterative provision
  • Outside of England
  • Does not have classes of pupils in eligible year groups to participate (Years 4, 5, 7, 8)
Show all 10Show fewer
  • Pupils and their parents/guardians:
  • Score below 7 on the Good Childhood Index (indicating low loneliness)
  • Parents/guardians do not consent, or pupils do not assent, to get support
  • Children and young people with severe learning disabilities who are unable to complete questionnaires

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Behavioural Science and Health, UCL

    London

Other trials in United Kingdom

About this study

Background: Social Prescribing is a mechanism of connecting patients with non-medical forms of support within the community and has been shown to improve loneliness. Yet update from young people has been lower than for adults. This is thought to be due to accessibility issues as young people are less likely to draw on primary care, where social prescribing is based, for wellbeing support. The INACT pilot sought to test the feasibility and acceptability of a Social Prescribing pathway via schools to support young people who are lonely through a randomised controlled trial. Findings suggested that study procedures, including the measures were appropriate and that Social Prescribing was deemed by young people, social prescribers and school staff as feasible, acceptable and suitable and there was evidence of impact in the social prescribing arm when compared to signposting. Given the positive pilot findings, the aim of the INACT full trial is to build upon the pilot work and conduct a clinical and cost effectiveness trial into the impact of Social Prescribing in schools for loneliness and low community connection, compared to signposting.

Methods: A minimum of 215 pupils reporting loneliness will be recruited across 30 mainstream schools in England and be randomly allocated to signposting or Social Prescribing. Pupils in the control group will receive signposting to sources of support from school staff. The co-produced social prescribing intervention includes up to 6 sessions with a Link Worker who will work with individuals to understand 'what matters to them' and connect them with local sources of support. The clinical and cost effectiveness of Social Prescribing for young people with loneliness will be assessed using measures of loneliness, mental health, wellbeing, quality of life, and service use. Data will be collected at baseline and 3, 6, and 12 months later. Qualitative interviews will also be conducted to explore barriers, facilitators, mechanisms of change and impact.

Discussion: INACT will provide evidence of the clinical and cost effectiveness of Social Prescribing in schools for supporting young people experiencing loneliness. It will also establish what types of community and social activities young people engage in and what factors affect participation.

Conditions
Loneliness
Being tested
Social Prescribing, Signposting
Keywords
Loneliness, Social Prescribing, Schools, Pupils

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Social PrescribingBehavioural

    SP is a person-centred approach to wellbeing involving the co-development of a non-clinical prescription, between an individual (i.e. young person) and Link Workers (LWs), based on the perceived difficulties for the referral and the YPs values, needs and preferences. LWs have a good knowledge of their local areas, via community asset mapping and networking, allowing them to connect individuals with different types of available support and activities. Typically, SP ranges from 6-12 sessions (average 8 sessions: unpublished data from sites) with a LW over an 8-week period. Sessions may take place online, via phone call, or in person. As part of this process, LWs draw on psychological skills such as motivational interviewing and behavioural activation as well as employ problem solving and goal setting. Following the identification of issues and preferences, the LW will discuss with the YP what the available local activities and support structures are that best match their preferences.

  • SignpostingBehavioural

    Those in the control group will receive signposting to activities and local sources of support in their communities. This will consist of school pastoral staff meeting with YP identified as lonely and providing them with a leaflet detailing the same local sources of support identified by the LW from asset mapping.

Study groups in NCT07154225
Study groupRoleWhat they receive
Social PrescribingExperimentalSP is a person-centred approach to wellbeing involving the co-development of a non-clinical prescription, between an individual (i.e. young person) and Link Workers (LWs), based on the perceived difficulties for the referral and the YPs values, needs and preferences. LWs have a good knowledge of their local areas, via community asset mapping and networking, allowing them to connect individuals with different types of available support and activities. Typically, SP ranges from 6-12 sessions (average 8 sessions: unpublished data from sites) with a LW over an 8-week period. Sessions may take place online, via phone call, or in person. As part of this process, LWs draw on psychological skills such as motivational interviewing and behavioural activation as well as employ problem solving and goal setting. Following the identification of issues and preferences, the LW will discuss with the YP what the available local activities and support structures are that best match their preferences.
Receives: Behavioral: Social Prescribing
SignpostingActive comparatorThose in the control group will receive signposting to activities and local sources of support in their communities. This will consist of school pastoral staff meeting with YP identified as lonely and providing them with a leaflet detailing the same local sources of support identified by the LW from asset mapping.
Receives: Behavioral: Signposting

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Loneliness

    Measured using the Good Childhood Index containing 3 questions on a 3-point Likert scale (scoring between 3-9). Higher scores indicate higher reported loneliness. Baseline, 3, 6 and 12 months

    Measured: Baseline, 3, 6 and 12 months

Secondary outcomes (10)
  1. Wellbeing

    Measures using the Wellbeing subscale (Kidscreenn-52) which contains 6 questions each on a five-point Likert scale (scoring between 6-30). Higher scores indicate greater well-being.

    Measured: Baseline, 3, 6 and 12 months

  2. Mental health (emotional difficulties)

    Measured using the Emotional difficulties subscale (Me and My feelings questionnaire) which contains 10 questions on a 3-point Likert scale (scoring between 0-20). Higher scores indicate higher emotional difficulties.

    Measured: Baseline, 3, 6 and 12 months

  3. Service use

    Measures using the Client Service Receipt of Inventory which contains 11 questions on a five-point Likert scale. Scoring can be looked at by individual items (i.e. score between 1-5) or by scoring all items (i.e. scores between 11-55). Higher scores indicate more contact with a service/services.

    Measured: Baseline, 3, 6 and 12 months

  4. Quality of Life

    Measured using the CHU-9D which contains 9 questions on a five-point Likert scale (scoring between 1-5). Higher scores indicate higher quality of life.

    Measured: Baseline, 3, 6 and 12 months

  5. Stress

    Measured using the Perceived Stress Scale 4 which assesses stress using 4 questions on a five-point Likert scale (scoring between 0-16). Higher scores indicate higher levels of perceived stress (secondary school pupils only)

    Measured: Baseline, 3, 6 and 12 months

  6. Emotion Regulation

    Emotion Regulation Index for Children and Adolescents is assessed using 16 items on a five-point Likert scale (scoring between 1-5). Higher scores indicate greater emotion regulation.

    Measured: Baseline, 3, 6 and 12 months

  7. Intervention Acceptability

    Measured using a single item adapted from the NHS Friends and Family Test on a five-point Likert scale . Higher scores indicate higher acceptability. Social prescribing arm only.

    Measured: 3, 6, and 12 months

  8. Intervention Feasibility (School Staff and Link Workers),

    Measured using the Feasibility of Intervention Measure (FIM) which contains 4 questions each on a five-point Likert scale (scoring between 4-20). Higher scores indicate higher intervention feasibility.

    Measured: Approx 3 months after intervention delivery has begun

  9. Intervention Acceptability (School Staff and Link Workers)

    Measured using the Acceptability of Intervention Measure (AIM) which contains 4 questions each on a five-point Likert scale (scoring between 4-20). Higher scores indicate higher intervention acceptability.

    Measured: Approx 3 months after intervention delivery has begun

  10. Intervention Appropriateness (School Staff and Link Workers)

    Measured using the Intervention Appropriateness Measure (IAM) which contains 4 questions each on a five-point Likert scale (scoring between 4-20). Higher scores indicate higher intervention appropriateness. 3 months

    Measured: Approx 3 months after intervention delivery has begun

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Sep 2025
  2. Study start15 Sep 2025
  3. Primary completion31 Jan 2027 (estimated)
  4. Study completion30 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
215 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07154225
Sponsor's protocol ID
1207
Acronym
INACT
Status last verified
May 2026
First submitted
26 Aug 2025
Last updated
12 May 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Some IPD data will be shared but specific data is being currently discussed with the funder. We will update this record when we know more.

Questions about this trial

What is this clinical trial studying?

A study testing Social Prescribing and Signposting in people with Loneliness, run by University College, London at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 12 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Loneliness (time frame: Baseline, 3, 6 and 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in